PAPER
Electrochemical Formation of Methoxy- and Cyano(phenylazo)alkanes
2061
13C NMR (CDCl3): d = 14.58 (CH3), 16.25 (CH2), 36.81 (CH2),
50.49 (CH3O), 101.19 (C), 122.28 (CH), 128.96 (CH), 130.55 (CH),
152.05 (C).
Anal. Calcd for C16H24N2O (260.37): C, 73.80; H, 9.29; N, 10.76.
Found: C, 73.74; H, 9.23; N, 10.46.
1-Cyano-1-phenylazoethane (3a)
Mp 151–152 °C.
IR (CCl4): 3273, 2216, 1604, 1558, 1495, 1373, 1269, 1234 cm–1.
1H NMR (acetone-d6): d = 2.1 (br s, 3 H, CH3), 6.8–7.5 (m, 5 H, Ar),
9.50 (br s, 1 H, CH).
13C NMR (acetone-d6): d = 15.07 (CH3), 114.43 (CH), 115.73 (CH),
119.19 (CN), 122.53 (CH), 129.66 (CH), 140.07 (C).
MS (EI): m/z (%) = 129 ([M – PhN2]+, 100), 87 (16), 77 (29), 54
(39), 44 (48), 39 (20), 24 (10).
MS(CI): m/z = 235 (M + 1)+.
HRMS: m/z calcd for C8H17O: 129.1279; found: 129.1322 (M –
PhN2)+.
Anal. Calcd for C14H22N2O (234.33): C, 71.75; H, 9.46; N, 11.96.
Found: C, 71.91; H, 9.54; N, 11.97.
MS (EI): m/z (%) = 159 (M+, 56), 132 (20), 92 (51), 91 (100), 77
1-Methoxy-1-phenylazocyclohexane (2f)
(23), 65 (42), 39 (18), 27 (HCN+, 3).
Bp 110–112 °C/1.3 mbar.
HRMS: m/z calcd for C9H9N3: 159.0794; found: 159.0766 (M+).
IR (neat): 2936, 2858, 1452, 1279, 1259, 1186, 1163, 1146, 1088,
937, 766, 691 cm–1.
1H NMR (CDCl3): d = 1.3–2.0 (m, 10 H, 5 × CH2), 3.45 (s, 3 H,
CH3O), 7.3–7.8 (m, 5 H, Ar).
Anal. Calcd for C9H9N3 (159.19): C, 67.90; H, 5.70; N, 26.40.
Found: C, 67.94; H, 5.81; N, 26.41.
1-Cyano-1-phenylazobutane (3b)
Mp 97–98 °C.
13C NMR (CDCl3): d = 22.19 (CH2), 25.41 (CH2), 32.01 (CH2),
49.92 (CH3O), 98.71 (C), 122.33 (CH), 128.96 (CH), 130.63 (CH),
152.05 (C).
IR (CCl4): 3261, 2966, 2876, 2218, 1605, 1506, 1497, 1234,
1171cm–1.
MS (EI): m/z (%) = 113 ([M – PhN2]+, 100), 81 (78), 77 (31), 71
(14), 50 (16), 44 (32), 39 (18).
MS (CI): m/z = 219 (M + 1)+.
1H NMR (CDCl3): d = 1.07 (t, 3 H, J = 7 Hz, CH3), 1.75 (heptet, 2
H, J = 7 Hz, CH2), 2.2–2.4 (m, 2 H, CH2), 6.7–7.5 (m, 5 H, Ar), 8.26
(br s, 1 H, CH).
13C NMR (CDCl3): d = 13.76 (CH3), 18.85 (CH2), 28.91 (CH2),
114.06 (CH), 117.72 (CH), 120.17 (CN), 122.73 (CH), 129.41
(CH), 142.64 (C).
HRMS: m/z calcd for C7H13O: 113.0966; found: 113.1020 (M –
PhN2)+.
Anal. Calcd for C13H18N2O (218.29): C, 71.52; H, 8.31; N, 12.83.
Found: C, 71.55; H, 8.45; N, 12.77.
MS (EI): m/z (%) = 187 (M+, 84), 158 (28), 105 (30), 92 (48), 91
(100), 77 (85), 65 (43), 39 (20), 27 (HCN+, 8).
1-Methoxy-1-phenylazocyclooctane (2g)
HRMS: m/z calcd for C11H13N3: 187.1109; found: 187.1148 (M+).
Bp 132–134 °C/1.3 mbar.
Anal. Calcd for C11H13N3 (187.24): C, 70.56; H, 7.00; N, 22.44.
Found: C, 70.69; H, 7.16; N, 22.51.
IR (neat): 2926, 2851, 1474, 1457, 1231, 1155, 1136, 1072, 766,
691 cm–1.
2-Cyano-2-phenylazopropane (3c)
Bp 95–97 °C/1.3 mbar.
1H NMR (CDCl3): d = 1.3–2.1 (m, 14 H, 7 × CH2), 3.45 (s, 3 H,
CH3O), 7.3–7.8 (m, 5 H, Ar).
IR (neat): 2990, 2937, 2241, 1524, 1479, 1456, 1364, 1238, 1171,
1150, 768, 689 cm–1.
1H NMR (CDCl3): d = (s, 6 H, 2 × CH3), 7.3–7.8 (m, 5 H, Ar).
13C NMR (CDCl3): d = 21.01 (CH2), 24.43 (CH2), 28.10 (CH2),
30.58 (CH2), 50.25 (CH3O), 101.03 (C), 122.24 (CH), 128.92 (CH),
130.47 (CH), 151.97 (C).
MS (EI): m/z (%) = 141 ([M – PhN2]+, 100), 109 (22), 77 (34), 67
(48), 50 (13), 45 (16), 44 (20), 39 (24).
13C NMR (CDCl3): d = 25.45 (CH3), 67.92 (C), 120.37 (CN),
122.85 (CH), 129.13 (CH), 131.77 (CH), 150.83 (C).
MS(CI): m/z = 247 (M + 1)+.
MS (EI): m/z (%) = 144 (6), 105 (62), 78 (21), 77 (100), 51 (50), 41
(11), 27 (HCN+, 4).
HRMS: m/z calcd for C9H17O: 141.1279; found: 141.1320 (M –
PhN2)+.
MS (CI): m/z = 174 (M + 1)+.
+
Anal. Calcd for C15H22N2O (246.34): C, 73.13; H, 9.00; N, 11.37.
Found: C, 73.05; H, 9.12; N, 11.11.
HRMS: m/z calcd for C6H5N2: 105.0453; found: 105.0443 (PhN2 ).
Anal. Calcd for C10H11N3 (173.21): C, 69.34; H, 6.40; N, 24.26.
Found: C, 69.02; H, 6.58; N, 23.95.
1-Methoxy-1-phenylazocyclononane (2h)
Bp 156–158 °C/2.0 mbar.
IR (neat): 2926, 2851, 1740, 1663, 1601, 1450, 1094, 764, 691 cm–1.
4-Cyano-4-phenylazoheptane (3e)
Bp 124–126 °C/2.0 mbar.
1H NMR (CDCl3): d = 1.3–2.2 (m, 16 H, 8 × CH2), 3.36 (s, 3 H,
IR (neat): 2963, 2876, 2237, 1524, 1466, 1456, 1144, 770, 691 cm–1.
1H NMR (CDCl3): d = 0.94 (t, 6 H, J = 7 Hz, 2 × CH3), 1.1–1.8 (m,
4 H, 2 × CH2), 1.9–2.3 (m, 4 H, 2 × CH2), 7.3–7.8 (m, 5 H, Ar).
13C NMR (CDCl3): d = 13.93 (CH3), 17.71 (CH2), 39.74 (CH2),
76.96 (C), 118.82 (CN), 122.81 (CH), 129.13 (CH), 131.57 (CH),
150.95 (C).
CH3O), 7.3–7.9 (m, 5 H, Ar).
13C NMR (CDCl3): d = 18.94 (CH2), 22.44 (CH2), 27.57 (CH2),
28.59 (CH2), 50.53 (CH3O), 102.17 (C), 122.28 (CH), 128.92 (CH),
130.51 (CH), 151.97 (C).
MS (EI): m/z (%) = 155 ([M – PhN2]+, 100), 81 (60), 77 (34), 67
(27), 55 (26), 41 (24).
MS (CI): m/z = 261 (M + 1)+.
MS (EI): m/z (%) = 172 (8), 105 (39), 77 (100), 51 (15), 41 (10), 27
(HCN+, 7).
HRMS: m/z calcd for C10H19O: 155.1436; found: 155.1402 (M –
MS (CI): m/z = 230 (M + 1) +.
PhN2)+.
+
HRMS: m/z calcd for C6H5N2: 105.0453; found: 105.0421 (PhN2 ).
Synthesis 2003, No. 13, 2057–2063 © Thieme Stuttgart · New York